How can clinicians help patients make decisions consistent with their values?

August 25, 2009

Communication in healthcare: how can clinicians help patients make decisions consistent with their values?

In a pair of trials carried out over the Internet, Cheryl Carling and colleagues from the Norwegian Knowledge Centre for the Health Services (Oslo, Norway) attempted to understand how information should best be presented to individuals in order to help them make healthcare choices that are most consistent with their values. The findings are published this week in the open-access journal , and a linked editorial discusses the relevance of the results for decision making in healthcare.

Previous research shows clearly that, when presenting treatment options to patients, the type of statistic chosen to illustrate the risks and benefits of treatment may affect the patient's choice. For example, even when the actual data are equivalent, a patient is more likely to choose invasive therapy if the outcomes of treatment are presented in terms of likely survival as compared to the likely risk of dying. However, Carling and colleagues also wanted to understand these effects and how they related to an individual's values—which they define as the "relative importance of the desirable and undesirable effects of an intervention."

Both trials were carried out via the Internet, and were advertised on Norwegian television. On logging on to the study websites, information about the study was presented to participants and some details collected from them regarding baseline information and their values in relation to treatment. Participants were then randomized to different displays regarding the risks and benefits of different treatment options. One study randomized 2,978 participants who then viewed six alternative presentations of the likely reduction in risk of coronary after taking statins. The other trial randomized 1,760 people to four different displays (or no information) regarding the likely effects of antibiotics on sore throat. Both trials show that as participants' values change, their decision as to whether to opt for (or seek) treatment also change. For example, in the statins trial, participants who are more concerned about the preventio n of are more likely to choose to take statins.

In addition, some ways of presenting information about risk were found to be more "persuasive" in motivating participants to opt for treatment, irrespective of their values. Overall, Carling and colleagues found that, in the statins trial, presenting risk as natural frequencies (whole numbers of people affected, per 100 population) were the best understood, gave participants most confidence in their decision, and were the most appropriate tool to use for presenting these type of data. In the "sore throat" trial, bar charts showing likely duration of symptoms were found to be similarly the most appropriate tool in helping participants make decisions consistent with their values.

The limitations of the studies include the fact that participants were more likely to be young and well-educated relative to the general population, and that the studies involved participants imagining their response in relation to two hypothetical scenarios, rather than actual decision making by patients. A previous pilot trial establishing the feasibility of carrying out this type of study over the Internet was published in PLoS ONE (http://dx.doi.org/10.1371/journal.pone.0003693).

In this month's related editorial the PLoS Medicine editors question the nature and effects of shared on patient care and subsequent treatment. The editors discuss the criteria for when shared decisions between patient and healthcare provider should be made, how different forms of data presentation can deepen a patient's understanding of possible treatment options, and how certain presentations can also prove unfairly persuasive. Linking to the two research articles by Cheryl Carling and colleagues, the editorial analyses the best ways for healthcare providers to be as informative as possible, whilst maintaining objectivity and a respect for patients' values prior to treatment.

More information: Carling CLL, Kristoffersen DT, Flottorp S, Fretheim A, Oxman AD, et al. (2009) The Effect of Alternative Graphical Displays Used to Present the Benefits of Antibiotics for Sore Throat on Decisions about Whether to Seek Treatment: A Randomized Trial. PLoS Med 6(8): e1000140. doi:10.1371/journal.pmed.1000140

Source: Public Library of Science (news : web)


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - not rated yet


August 25, 2009 all stories

Comments: 0

not rated yet
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories




  • hide
  • Relevant PhysicsForums posts

Other News

Scientists reveal 'protector' gene behind 50-fold increase in number of bowel tumours

Medicine & Health / Cancer

created 8 minutes ago | popularity not rated yet | comments 0

(PhysOrg.com) -- Cancer Research UK scientists have shown that deleting a single gene can increase the average number of tumours in the bowel by 50-fold, according to research published in PNAS today.


An end to sleep problems? Researchers discover enzyme behind effects of sleep deprivation

Medicine & Health / Research

created 1hour ago | popularity not rated yet | comments 0

There is hope for those who miss one night too many or whose children keep them up at night. The unwelcome effects of a bad night's sleep - forgetfulness, impaired mental performance - can be dealt with by reducing the concentration ...


Ginkgo biloba doesn’t prevent cardiovascular events but may have potential peripheral artery disease benefits

Medicine & Health / Research

created 1hour ago | popularity not rated yet | comments 0

(PhysOrg.com) -- Ginkgo biloba didn’t prevent cardiovascular death or major events such as heart attack and stroke in people age 75 and older, but the herb may affect peripheral vascular disease, according to research reported ...


Implant-based cancer vaccine is first to eliminate tumors in mice

Implant-based cancer vaccine is first to eliminate tumors in mice

Medicine & Health / Cancer

created 19 hours ago | popularity 4.7 / 5 (22) | comments 4

(PhysOrg.com) -- A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, scientists report this week in the journal ...


Brain's endocannabinoid signaling pathway kept in check by two enzymes

Medicine & Health / Research

created 17 hours ago | popularity 4 / 5 (4) | comments 1

(PhysOrg.com) -- A research team has shown that blocking the degradation of two naturally occurring cannabinoids in the endocannabinoid signaling pathway of the brain produces marijuana-like behavioral effects in mice, according ...